• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Recognition List Number: 029 Publication Date: 08/20/2012 

Part B: SUPPLEMENTARY INFORMATION

Recognition Number 7-179: CLSI M27-S3, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Third Informational Supplement. (InVitro Diagnostics)

Date of Standard: 2008. 
Address of Standards Organization:
  Clinical Laboratory Standards Institute (CLSI)
  950 West Valley Road
  Suite 2500
  Wayne, PA 19087
 
CDRH Office and Division Associated with Recognized Standards:
OFFICE OF IN VITRO DIAGNOSTICS AND RADIOLOGICAL HEALTH (OIR)
DIVISION OF MICROBIOLOGY (DMD)
Devices Affected:
Antifungal Susceptibility minimum inhibitory concentration (MIC) and disk diffusion devices
Processes Affected:
510(k), Pre-IDE
Type of Standard:
 Horizontal, National
Extent of Recognition:
Complete standard
Related CFR Citations and Product Codes:
Regulation
Number
Device Name Device
Class
Product
Code
§866.1620 Discs, Elution Class 2 LTX
§866.1620 Susceptibility Test Discs, Antimicrobial Class 2 JTN
 
Regulation
Number
Device Name Device
Class
Product
Code
§866.1640 Susceptibility Test Plate, Antifungal Class 2 NGZ
 
Regulation
Number
Device Name Device
Class
Product
Code
§866.1700 Culture Media, Antifungal, Susceptibility Test Class 2 MJE
 
Relevant Guidance:
There is no relevant guidance developed at this time.
FDA Technical Contact:
  Yvonne Shea
  FDA/CDRH/OIVD
  10903 New Hampshire Avenue Building 66, Room 5510
  Silver Spring MD 20993
  301/796-0576
  Email: yvonne.shea@fda.hhs.gov
-
-